Prader-Willi Syndrome: all 142 studies
Page 2 of 2. Open to participants first (23), then studies with results posted, then the rest; newest registration first within each.
- Effects of Intranasal Administration of Oxytocin in Adults With Prader-Willi SyndromeCompletedNCT02804373Phase 2/3
- Post Exercise Irisin Levels in PWS PatientsStatus unknownNCT02728544Not applicable
- Sleep Abnormalities in Rare Genetic Disorders: AS, RTT, and PWCompletedNCT02670694
- PWS European Blood Bank for Infants and Controls From 0 to 48 MonthsCompletedNCT02529085Not applicable
- Macronutrient Regulation of Ghrelin and Peptide YYCompletedNCT02464514Not applicable
- SNP-based Microdeletion and Aneuploidy RegisTry (SMART)CompletedNCT02381457
- Diagnosis of Central Adrenal Insufficiency in Patients With Prader-Willi SyndromeCompletedNCT02368379Not applicable
- Deep Brain Stimulation for the Treatment of Obesity in Patients With Prader-Willi SyndromeStatus unknownNCT02297022Phase 1
- PREPL in Health and DiseaseActive, not recruitingNCT02263781Not applicable
- Growth Hormone in Children Under 2 Years With Prader-Willi in Hospital of SabadellCompletedNCT02205450
- Study to Assess the Efficacy and Safety of Eutropin in Prader-Willi SyndromeCompletedNCT02204163Phase 3
- Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Beloranib) in Obese Subjects With Prader-Willi SyndromeTerminatedNCT02179151Phase 3
- Family-based Intervention for Youth With Prader-Willi Syndrome: The Active Play at Home StudyStatus unknownNCT02058342Not applicable
- Clinical Study of Diazoxide Choline Controlled-Release Tablet (DCCR) in Patients With Prader-Willi SyndromeCompletedNCT02034071Phase 1/2
- Oxytocin Trial in Prader-Willi SyndromeCompletedNCT02013258Phase 1
- Prader-Willi Syndrome Macronutrient StudyCompletedNCT02011360Not applicable
- Hypoglycemia in Prader-Willi SyndromeCompletedNCT01897363
- An Efficacy, Safety, and Pharmacokinetics Study of Beloranib in Obese Subjects With Prader-Willi SyndromeCompletedNCT01818921Phase 2
- Plasma Adiponectin Level and Sleep Structures in Children With Prader-Willi SyndromeCompletedNCT01622751
- Ghrelin Suppression by Octreotide in Prader-WilliStatus unknownNCT01613495Not applicable
- Tolerance of Intranasal Administration of OT in Prader-Willi Newborn BabiesCompletedNCT01548521Phase 1/2
- Liraglutide Use in Prader-Willi SyndromeTerminatedNCT01542242Phase 4
- The Intestinal Function in People With Prader-Willi SyndromeCompletedNCT01523288
- Aromatase Inhibitor in Bone Maturation, Children With Silver Russell or Prader-Willi SyndromeStatus unknownNCT01520467Not applicable
- Plasma Adiponectin Level and Vascular Endothelial and Smooth Muscle Cell Function in Children With Prader-Willi SyndromeCompletedNCT01479322
- Characterization of Transcriptional Regulators of Ghrelin Hormone Which Causes Genetic ObesityCompletedNCT01404624
- Bioequivalence of Two Somatropin Products (Norditropin® Versus Genotropin®) in Healthy Adult VolunteersCompletedNCT01401244Phase 1
- Is There a Sensibility Increased in the Growth Hormone at Child With Prader-Willi Syndrome?CompletedNCT01298180Phase 4
- Comparative Study Between Prader-Willi Patients Who Take Oxytocin Versus PlaceboCompletedNCT01038570Phase 2
- Cortisol Activity in Patients With Prader-Willi Syndrome and Healthy ControlsCompletedNCT00932932
- Exploring Stress and Coping Behaviors of the Major Carer Whose Children With Prader-Willi SyndromeStatus unknownNCT00808548
- Increased Expression of Adiponectin Receptor 2 in the Mononuclear Cells in Children With Prader-Willi SyndromeCompletedNCT00800852
- Behavioral Treatment of Obsessive-Compulsive Symptoms in Youth With Prader-Willi Syndrome: A Pilot ProjectCompletedNCT00742664Phase 1/2
- Retrospective Observational Study on Efficacy and Safety of Norditropin® in Children With Prader-Willi SyndromeCompletedNCT00705172
- Effect of Rimonabant on Weight Gain and Body Composition in Adults With Prader Willi SyndromeTerminatedNCT00603109Phase 3
- Gut Derived Hormones, Body Composition and Metabolism in Prader-Willi SyndromeCompletedNCT00551343Not applicable
- Correlation of Hyperghrelinemia With Carotid Artery Intima-Media Thickness in Children With Prader-Willi SyndromeCompletedNCT00474643
- Characteristics of Prader-Willi Syndrome and Early-onset Morbid ObesityCompletedNCT00375089
- Nordic Study on the Effects of Growth Hormone (Norditropin SimpleXx) Treatment in Adults With Prader-Willi SyndromeCompletedNCT00372125Not applicable
- Prader-Willi Syndrome and AppetiteTerminatedNCT00175305Phase 3
- Treatment of Self-Injurious Behavior in Individuals With Prader-Willi SyndromeCompletedNCT00065923Not applicable
- Study of Phenotype and Genotype Correlations in Patients With Contiguous Gene Deletion SyndromesCompletedNCT00004351